180 related articles for article (PubMed ID: 17285151)
1. Impaired insulin signaling and the pathogenesis of Alzheimer's disease.
Revill P; Moral MA; Prous JR
Drugs Today (Barc); 2006 Dec; 42(12):785-90. PubMed ID: 17285151
[TBL] [Abstract][Full Text] [Related]
2. Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease.
de la Monte SM; Wands JR
J Alzheimers Dis; 2005 Feb; 7(1):45-61. PubMed ID: 15750214
[TBL] [Abstract][Full Text] [Related]
3. The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment.
Watson GS; Craft S
CNS Drugs; 2003; 17(1):27-45. PubMed ID: 12467491
[TBL] [Abstract][Full Text] [Related]
4. Genetic discoveries as the basis of personalized therapy: rosiglitazone treatment of Alzheimer's disease.
Hsueh W
Pharmacogenomics J; 2006; 6(4):222-4. PubMed ID: 16865098
[No Abstract] [Full Text] [Related]
5. Type 2 Diabetes Mellitus and Alzheimer's Disease: Role of Insulin Signalling and Therapeutic Implications.
Tumminia A; Vinciguerra F; Parisi M; Frittitta L
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30355995
[TBL] [Abstract][Full Text] [Related]
6. Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease.
Hölscher C
Biochem Soc Trans; 2011 Aug; 39(4):891-7. PubMed ID: 21787319
[TBL] [Abstract][Full Text] [Related]
7. Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer's disease.
Alagiakrishnan K; Sankaralingam S; Ghosh M; Mereu L; Senior P
Discov Med; 2013 Dec; 16(90):277-86. PubMed ID: 24333407
[TBL] [Abstract][Full Text] [Related]
8. Antidiabetic drugs for Alzheimer's and Parkinson's diseases: Repurposing insulin, metformin, and thiazolidinediones.
Cardoso S; Moreira PI
Int Rev Neurobiol; 2020; 155():37-64. PubMed ID: 32854858
[TBL] [Abstract][Full Text] [Related]
9. Non-insulin-dependent diabetes mellitus and Alzheimer's disease.
Landi F; Bernabei R; Gambassi G
J Am Geriatr Soc; 1997 May; 45(5):654-5. PubMed ID: 9158597
[No Abstract] [Full Text] [Related]
10. Insulin signalling in Alzheimer's disease and diabetes: from epidemiology to molecular links.
Ribe EM; Lovestone S
J Intern Med; 2016 Nov; 280(5):430-442. PubMed ID: 27739227
[TBL] [Abstract][Full Text] [Related]
11. Diabetes drugs and neurological disorders: new views and therapeutic possibilities.
Patrone C; Eriksson O; Lindholm D
Lancet Diabetes Endocrinol; 2014 Mar; 2(3):256-62. PubMed ID: 24622756
[TBL] [Abstract][Full Text] [Related]
12. [FUNCTIONAL ACTIVITY OF THE BRAIN INSULIN SIGNALING SYS TEM IN NORM AND IN TYPE 2 DIABETES MELLITUS].
Shpakov AO
Ross Fiziol Zh Im I M Sechenova; 2015 Oct; 101(10):1103-27. PubMed ID: 26827491
[TBL] [Abstract][Full Text] [Related]
13. What your doctor is reading.
Clark W
Diabetes Self Manag; 2011; 28(1):66, 68, 70. PubMed ID: 21323076
[No Abstract] [Full Text] [Related]
14. The impairment of insulin signaling in Alzheimer's disease.
Candeias E; Duarte AI; Carvalho C; Correia SC; Cardoso S; Santos RX; Plácido AI; Perry G; Moreira PI
IUBMB Life; 2012 Dec; 64(12):951-7. PubMed ID: 23129399
[TBL] [Abstract][Full Text] [Related]
15. Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease.
Ferreira ST; Clarke JR; Bomfim TR; De Felice FG
Alzheimers Dement; 2014 Feb; 10(1 Suppl):S76-83. PubMed ID: 24529528
[TBL] [Abstract][Full Text] [Related]
16. Shared links between type 2 diabetes mellitus and Alzheimer's disease: A review.
Mittal K; Katare DP
Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S144-9. PubMed ID: 26907971
[TBL] [Abstract][Full Text] [Related]
17. Links between Alzheimer's disease and diabetes.
Sun MK; Alkon DL
Drugs Today (Barc); 2006 Jul; 42(7):481-9. PubMed ID: 16894402
[TBL] [Abstract][Full Text] [Related]
18. Insulin, diabetes mellitus, Alzheimer's disease, and apolipoprotein E.
Gambassi G; Bernabei R
Neurology; 1998 Sep; 51(3):925-6. PubMed ID: 9748080
[No Abstract] [Full Text] [Related]
19. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes.
Gupta A; Bisht B; Dey CS
Neuropharmacology; 2011 May; 60(6):910-20. PubMed ID: 21277873
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone effects to ameliorate Alzheimer's disease pathogenic features: insulin signaling and neurotrophic factors.
Castillo-Quan JI
J Neuropsychiatry Clin Neurosci; 2009; 21(3):347-8. PubMed ID: 19776322
[No Abstract] [Full Text] [Related]
[Next] [New Search]
